(Q44257242)

English

Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma

scientific article

Statements

Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma (English)
Elisabeth I Heath
Barbara A Burtness
Lawrence Kleinberg
Ronald R Salem
Stephen C Yang
Richard F Heitmiller
Marcia I Canto
Jonathan P S Knisely
Mark Topazian
Elizabeth Montgomery
Nancy Tsottles
Yazdi Pithavala
Bridget Rohmiller
Mary Collier
Arlene A Forastiere
1 March 2006
135-140

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit